Please login to the form below

Not currently logged in
Email:
Password:

Idea Pharma taps Astellas and Xention for new recruits

The phase II strategy consultancy appoints four new members of staff, including Astellas’ Amy Wasserman and Xention’s Calum Graham

Phase II strategy consultancy Idea Pharma has appointed four new members of staff, including Astellas' Amy Wasserman and Xention's Calum Graham.

Wasserman joins Idea Pharma as director of client value (US) after more than four years at Astellas Pharma US and before that stints at Janssen-Ortho and Solvay.

Meanwhile, Graham has over 20 years' pharma experience, including two years with Xention as director of business development. Prior to that he spent six years at GlaxoSmithKline leading global studies across a wide range of therapeutic areas.

Idea Pharma has also appointed Tristan Allen as European account manager and Claire Hales as office administrator (UK).

Allen was most recently an independent marketing and business development consultant while Hales joins Idea Pharma from the steel coating industry.

14th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics